Short interfering ribonucleic acid (siRNA) for oral administration
US8957041B2 · kind B2 · utility
0Cited by
20References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 2012 |
| Grant date | Feb 17, 2015 |
| Priority date | — |
| Expiry date | Apr 30, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Short interfering ribonucleic acid (siRNA) for oral administration, said siRNA comprising two separate RNA strands that are complementary to each other over at least 15 nucleotides, wherein each strand is 49 nucleotides or less, and wherein at least one of which strands contains at least one chemical modification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.